BackAlterity Therapeutics Limited Overview
Alterity Therapeutics Limited

Alterity Therapeutics Limited P/E Ratio

Valuation check: PRNAF's P/E ratio is -2.26, below the Healthcare sector average of 21.65.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-2.26

P/E Ratio

-2.26

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Alterity Therapeutics Limited (PRNAF) FAQ

As of the most recent data, PRNAF shows a P/E ratio of -2.26. That is below the Healthcare sector average of 21.65. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 21.65. Alterity Therapeutics Limited is at -2.26, which is lower that average. That is roughly 110.4% below the sector mean. Use the comparison chart on this page to see how PRNAF stacks up against individual peers as well.

Investors watch PRNAF's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Alterity Therapeutics Limited's latest reading is -2.26. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Alterity Therapeutics Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -2.26) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 21.65, while PRNAF is at -2.26. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.